Published 3 days ago • loading... • Updated 3 days ago

INSP INVESTOR ALERT: Inspire Medical (INSP) Sued Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman

On Jan. 5, 2026, Rosen Law issued a New York notice reminding investors of the Inspire Class Period and deadline to seek lead-plaintiff status.
The complaint alleges defendants misrepresented market demand for Inspire V and failed to disclose launch steps, while Rosen Law is soliciting class members to join the action.
Rosen directs eligible investors to submit an online form or call Phillip Kim, Esq., toll-free at 866-767-3653, or email case@rosenlegal.com for details.
Affected purchasers of Inspire common stock may seek compensation without out-of-pocket fees through contingency-fee arrangements, and The Rosen Law Firm, P. A. says it recovered hundreds of millions for investors.
Investors are advised that a lead plaintiff serves as representative directing litigation, but until class certification investors must retain counsel, while Rosen highlights its $438 million recovery and warns some firms only refer clients.

Insights by Ground AI